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Abstract.  Type VI collagen, a widespread structural 
component of connective tissues, has been isolated in 
abundance from fetal bovine skin by a procedure in- 
volving bacterial collagenase digestion under nonre- 
ducing, nondenaturing conditions and gel filtration 
chromatography. Rotary shadowing electron micro- 
scopic analysis revealed that the collagen VI was pre- 
dominantly in the form of extensive intact microfibril- 
lar arrays. These microfibrils were seen in association 
with hyaluronan, which was identified by its ability to 
bind the G1 fragment of cartilage proteoglycan. Treat- 
ment with highly purified hyaluronidase largely dis- 
rupted the collagen VI microfibrils into component 
tetramers, double tetramers, and short microfibrillar 
sections. Subsequent incubation of disrupted collagen 
VI in the presence of hyaluronan facilitated a partial 
repolymerization of the microfibrils. In vitro binding 
studies have also demonstrated that type VI collagen 
binds hyaluronan with a relatively high affinity.  These 
studies demonstrate that a specific structural relation- 
ship exists between type VI collagen and hyaluronan. 
This association is likely to be of primary importance 
in the growth and remodeling processes of connective 
tissues. 
T 
HE extracellular matrices (ECMs) ~  of connective tis- 
sues are complex and highly diverse structures com- 
prising many different matrix components,  including 
the fibrillar  collagens,  proteoglycans,  and adhesive matrix 
glycoproteins. The spatiotemporal distributions of  these var- 
ious components and their complex molecular and cellular 
interactions  define the characteristic three-dimensional ar- 
rangements of each connective tissue which are important in 
regulating  events such as the proliferation,  migration and 
differentiation of cells. While the role of some matrix assem- 
blies is relatively easy to identify as exemplified by the pro- 
vision of tensile strength by the major collagen types I, 1I, 
and HI, the roles of other macromolecules are less clearly 
defined. Thus, type VI collagen and hyaluronan, both com- 
plex network-forming polymers and ubiquitous components 
of matrix, have been credited with important, though imper- 
fectly understood, roles in tissue organization and remodel- 
ing (Keene et al.,  1988; Bonaldo et al.,  1990; Evered and 
Whelan, 1988). 
Type VI collagen, which is expressed in virtually every  tis- 
sue examined so far (Timpl and Engel, 1987; Kielty et al., 
1991a), is synthesized by a wide range of different cell types 
(Hessle and Engvall, 1984; Chu et al., 1987; Peltonen et al., 
1990a;  Hatamochi et al.,  1989; Colombatti  and Bonaldo, 
1987; Kielty et al., 1990; Fleischmajer et al., 1991). It ap- 
pears to be an integral component of matrix with a pivotal 
influence on matrix organization and on attachment of cells 
within the ECM, both in normal development and tissue 
1. Abbreviation  used in this paper:  ECM, extracellular matrix. 
maintenance, and in several major disease states.  Indeed, 
perturbations  in collagen VI levels have been established in 
several major connective  tissue  disorders,  including  cuffs 
laxa (Crawford et al., 1985), neurofibroma (Fleischmajer et 
al., 1985), atherosclerosis (Kittelberger et al., 1990), diabe- 
tes (Mohan et al., 1990), rheumatoid arthritis (Okada et al., 
1990), and systemic sclerosis (Peltonen et al., 1990b). Col- 
lagen VI is essentially a coHagenous giycoprotein which is 
assembled  in  vivo  into  extensive  and  highly  flexible 
microfibrils  which form filamentous  networks interwoven 
among the major interstitial  structures such as  collagen 
fibrils, blood vessels, and nerves in the surrounding extracel- 
lular matrix (Bruns et al., 1986; Keene et at., 1988; Kielty 
et al., 1991b; Bray et al., 1990). The scope for collagen VI 
interactions  with other components of matrix is large,  al- 
though ~w associations  have been specified  so  far.  Two 
potential collagen VI-cell interactions  have, however, been 
identified. Sequence analysis has revealed within the triple- 
helical domains of the three collagen VI chains the presence 
of eleven RGD putative cell-adhesion sequences,  at least 
some of  which appear to be biologically significant (Aumail- 
Icy et al., 1990). An apparent protein-protein association of 
collagen VI with a membrane-associated chondroiffn  sul- 
phate proteoglycan (NG2) has also been reported (Stallcup 
et al.,  1990). In addition,  adhesion  of collagen VI to im- 
mobilized type I collagen has been demonstrated in vitro; 
this interaction may involve the repeating yon Willebrand 
factor-like motifs within the globular domains of the three 
chains (Chu et al., 1989; Koller et al., 1989; Bonaldo et al., 
1990). 
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disperse, high-Mr expanded coil structure (Evered and Whe- 
lan,  1988; Scott, 1989). It can occur as a free glycosamino- 
glycan (for example, in vitreous humor or synovial fluid), as 
a coat attached via receptors to cell surfaces, or as an inter- 
active part of proteoglycans such as aggrecan.  Hyaiuronan 
is present in all connective tissue matrices, but is a major 
constituent of embryonic ECM where it can be detected as 
early as gastrulation.  At this stage, it is thought to organize 
the ECM into a hydrated,  open lattice able to support and 
promote cell movements.  It is synthesized  on the inside of 
the plasma membrane by the enzyme, hyaluronan synthetase, 
and the repeating  disaccharide chains are extruded directly 
to the extracellular  space through  pores in the membrane 
(Prehm,  1988). There is recent rotary shadowing evidence 
and computer modeling information  that hyaluronan  is not 
only capable of forming defined secondary and tertiary struc- 
tures, but that it is fundamentally a network-forming  poly- 
mer (Scott et al., 1991). The specific mechanisms by which 
hyaiuronan interacts with embryonic cells, tissues, and other 
ECM components remain to be elucidated.  Hyaluronan has 
not been shown to be linked covalently to proteins.  However, 
specific hyaluronan-binding  proteins have now been isolated 
from various connective tissues (Mason et al.,  1989) and 
from cultures of fibroblasts (Carlstedt et al., 1983) and aortic 
endothelial cells (Morita et ai., 1990). Furthermore, cDNA 
sequence determinations have also shown that the hyaluronan- 
binding region of link protein, the G1 domain of cartilage 
proteoglycan,  and  a  cell  surface protein,  CIM4,  contain 
structurally  related  tandem  repeat  structures  (disulphide- 
bonded loops) which have been implicated  in binding  hyal- 
uronan (Krusius et al., 1987; Dudhia et al., 1990; Aruffo et 
al., 1990; Culty et al., 1990). Elevated levels of hyaluronan 
frequently occur in turnouts where it may act as a support 
for cell adhesion and locomotion (Knudson et al., 1988), and 
in diseases of connective tissues such as cirrhosis, sclerosis, 
and rheumatoid arthritis  (Engstrom-Lanrent,  1988). 
The abundance, codistribution, and putative roles in cell- 
matrix communications of type VI collagen and hyaiuronan 
in both normal developing tissues and certain disease condi- 
tions are suggestive of a relationship  between these distinct 
molecular entities.  We have extracted intact high-Mr assem- 
blies containing type VI collagen microfibrils and hyaluronan 
from fetal calf skin, and by a combined biochemical, immu- 
nological, and electron microscopic approach we have iden- 
tiffed a specific  structural association between these mole- 
cules which has important and far-reaching  implications  in 
health and disease. 
Materials and Methods 
Materials 
Fetal calves were obtained from the local abattoir within 1 h of maternal 
death. Bacterial collagenase  (type 1A), PMSF, N-ethylmaleimide (NEM), 
benzamidine, diaminobenzidine, DTT, NP-40, DNase I (EC 3.1.21) from 
bovine pancreas, high-Mr hyaluronan (from bovine vitreous humor), chon- 
droitin sulphate A and B (dermatan sulphate), heparan sulphate,  hyaiuroni- 
dase (EC 3.2.1.35) (type I-S from bovine testes, type IX from Streptomyces 
hyaiurolyticus),  hyalnronidase (EC 3.2.1.36)  (type  X  from leech), chon- 
droitinase ABC  (EC  4.2.2.4),  keratanase  (EC  3.2.1.103),  papain (EC 
3.4.22.2), cetyi pyridinium phosphate, and prestained noncollagenous  mo- 
lecular weight markers were obtained from the Sigma Chemical Company 
(Poole, Dorset, UK). Tween-20 was obtained from BDH Chemicals (Poole, 
Dorset, IRK). Sepharose CL-2B and PD10 desalting columns were supplied 
by Pharmacia-LKB (Milton Keynes,  Bucks,  ILK). Peroxidase-conjugated 
swine IgGs to rabbit immunoglobulins were supplied by Dakopatt Ltd. 
(High Wycombe, Bucks, UK). Alkaline phosphatase-conjugated anti-rab- 
bit IgG, biotinylated anti-rabbit IgG, alkaline phosphatase-conjugated ex- 
travidin,  and p-nitrophenyl phosphate (pNPP)  were  obtained from the 
Sigma Chemical Company. Mica sheets were obtained from TAAB Labora- 
tory Equipment Ltd.  (Reading,  Berks, UK).  The G1 fragment of porcine 
cartilage proteoglycan  which binds specifically  to hyaluronan was a gift 
from Dr.  Tim Hardingham and Dr.  Amanda Fosang  (Kennedy  Institute, 
London, UK) (Morgelin et al.,  1988; Fosang and Hardingham, 1989). 
1Issue Digestion and Solubilization 
Samples of skin (•2  g wet weight) were dissected and homogenized in 10 
ml of 0.05 M Tris-HC1, pH 7.4, containing 0.4 M NaC1, 0.01 M CaCI2, 2 
mM PMSF, and 10 mM NEM. Bacterial collagenasr  (type 1A) was added 
to a final concentration of 0.2 mg/ml, and the digestion allowed to proceed 
at 4~  for 18 h with gentle stirring. The digestions were terminated by addi- 
tion of EDTA to a final concentration of 15 raM. The digests  were cen- 
trifuged at 10,000 g for 30 rain and the supernatants, which contained sohi- 
bilized high-Mr  matrix assemblies,  were retained.  These extracts  were 
used in subsequent experiments.  In some experiments, high-Mr assemblies 
were isolated from skin after digestion with bacterial collagenase  for only 
4  h  at 22~  Skin samples  were also digested  for 18 h  with 0.2 mg/ml 
hyaluronidase  (from bovine testes) in 0.05 M sodium acetate, pH 6.0, con- 
taining 0.15 M NaC1, 2 mM EDTA, 2 mM PMSF, 5 mM benzamidine, and 
10 mM NEM. The salt extracts were all digested for 4 h at 22~  with 25 
/zg DNase I in 0.05 M Tris-HCl, pH 7.4, containing 0.4 M NaC1 and 0.05 M 
MgC12. 
Isolation and Purification of  Intact Collagen VI 
The salt extracts were chromatographed directly without concentration un- 
der nonreducing, nondenaturing conditions on a column (1.5 x  200 cm) of 
Sepharose CL-2B. The column was equilibrated and ehited at room temper- 
ature with 0.05 M Tris-HC1, pH 7.4, containing 0.4 M NaC1. An analytical 
column of Sepharose 2B (1  x  20 cm) was  used in some experiments. 
Column runs were constantly monitored at 280 nm and the column frac- 
tions comprising the void volume (Vo) and containing the excluded mate- 
rial, were pooled (preparation A). Intact collagen  VI microiibrils repre- 
sented  by  far  the  major  protein  of  this  high-Mr  material.  In  some 
experiments,  the excluded fraction was dialyzed extensively against distilled 
water,  freeze-dried,  and then subsequently stirred overnight at 4~  in 
0.05 M Tris-HCl, pH 7.4, containing 0.15 M NaC1. Under these conditions, 
the intact collagen VI remained undissolved (preparation B), which facili- 
tated the removal of soluble contaminants. 
Specific Enzyme Digestions 
The  salt extracts,  excluded  high-Mr  material  (preparation A)  and the 
purified collagen VI  (preparation B) obtained from  18-h bacterial col- 
lagenase digests of 2 g skin were subjected to digestion either for 3 h at 22~ 
or overnight at 4~  with a  range of highly specific  glycosaminoglycan- 
degrading enzymes, using a ratio of 1 U enzyme activity per sample con- 
raining 40/~g uronic acid and 10 rag protein approximately. Digestions with 
hyaluronidase  (Streptomyces  hyalurolyticns  or leech) were carried out in 
0.05 M sodium acetate, pH 6.0, containing 0.15 M NaCI,  2 mM EDTA, 2 
mM PMSE 5 mM benzamidine and 10 mM NEM. The buffer for the chon- 
droitinase ABC lyase digestions  was 0.05 M Tds-HC1,  pH 8.0, containing 
0.06 M sodium acetate, 2 mM PMSE 2 mM EDTA, 5 mM benzamidine, 
and 10 mM NEM, while keratanase digestions were carded out in 0.15 M 
Tris-HC1, pH 7.4, containing 2 mM PMSF, 5 mM benzamidine, and 10 mM 
NEM. Protein concentrations were determined by dry weight or by absor- 
bance at 230 or 280 nm, using type I collagen and BSA as standards.  Uronic 
acid determinations were carded out according to the method of Bitter and 
Muir (1962). 
Electrophoresis and Western Blotting 
The salt extracts,  excluded fractions (preparation A) and purified collagen 
VI (preparation B) were analyzed by discontinuous SDS-PAGE on 6.5 or 
8% gels (Laemmli, 1970) in the presence or absence of 10 mM DTT. Mo- 
lecular weights were determined by reference to standards, which were col- 
lagenous (types I and V collagens) and noncollagenous.  The prestained non- 
collagenons standards used were fumarase (Mr 48,500), pyruvate kinase 
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or with bacterial collagenase under nonreducing conditions, and gel filtration chromatography. (,4) Eleetrophoretic analysis on 6.5 % SDS- 
PAGE gels under reducing conditions of the proteins solub'tlized by hyaluronidase digestion (track 1) and bacterial collagenase digestion 
(track 2). The position of type I collagen in the hyaluronidase digests and of the Mr 140,000 c~I(VI)/e~2(VI)  component of type VI collagen 
in the bacterial collagenase digest (/arge arrowhead)  are shown.  (B) Digests were chromatographed  on a  column of Sepharose CL-2B 
under nonreducing, nondenaturing conditions. The column buffer was 0.4 M-Tris-HCI, pH 7.4. The bacterial collagenase profile is repre- 
sented as a continuous line, and the hyaluronidase profile as broken lines. Fractions were pooled as indicated by the bars. (C) Electrophoretic 
analysis on 6.5% SDS-PAGE gels under reducing conditions of the proteins present in the pooled fractions obtained after chromatography 
of bacterial collagenase-digested skin (Tracks 3-5).  The position of the cd(VI)/r  component is indicated. 
(Mr  58,000),  fructose-6-phosphate  kinase  (Mr  84,000),  ~galactosidase 
(Mr 116,000) and c~2-macroglobulin (Mr  180,000). Gels were stained  for 
protein using either Coomassie brilliant blue or silver stain. Western blot- 
ting was carried out as described by Kielty et al. (1990). Proteins were elec- 
trophoretically  transferred to nitrocellulose  filters, and incubated at room 
temperature  with antiserum  at appropriate  dilution.  The identification of 
type VI collagen was achieved using a 1:1,000 dilution of either or both of 
two polyclonal antisera  raised in rabbits to type VI collagen (Ayad et al., 
1989; Kielty et al., 1991b). One of these is known to recognize specifically 
the a3(VD chain and the other the od(V1)/cx2(VD  component. Positive reac- 
tions  were identified  after incubation  with second antibody, peroxidase- 
labeled swine IgGs to rabbit  immunoglobulins.  In some experiments,  the 
high-Mr excluded material (preparation A) and the purified intact collagen 
VI (preparation B) were also analyzed by SDS-PAGE on 2.5 % gels as previ- 
ously described  (Kielty et al., 1990), using thyroglobulin (Mr 669,000) as 
high-M~ standard. 
Analysis of  Glycosaminoglycans 
The glycosaminoglycan content of the extracts and of the excluded material 
(preparation A) was determined by electrophoresis on cellulose acetate (zip) 
plates  after papain  digestion and fractionation  of glycosan'anoglyeans by 
cetyl pyridinium precipitation as previously described (Scott et al., 1981). 
The glycosaminoglycans were visualized after staining with Alcian blue, 
and identified both by reference to standards (chondroitin sulphate, derma- 
tan sulphate, by~uronan,  and beparan sulphate) and by their susceptibility 
to digestion with various  specific glycosaminoglycan-degrading  enzymes 
(Streptomyces  hyaluronidase,  leech hyaluronidase,  chondroitinase  ABC 
lyase, keratanase, and heparanase).  The relative abundance of the different 
glycosaminoglycans present in each sample was determined by scanning the 
zip plates using an LKB laser scanning densitometer  at 632.8 rim. 
Binding of Glycosaminoglycans to Type VI Collagen 
ELISA-type solid phase assays of collagen VI-glycosaminoglycan interac- 
tions  were conducted  on 96-well plates  (Nunclon).  All incubations  were 
carried out in PBS minus Mg  2+ and Ca  2+. Wells were coated overnight at 
4~  with 5 or 10 t~g soluble intact bovine collagen VI (preparation  A) in 
100/h PBS. To block additional protein binding sites, the wells were in- 
cubated in PBS containing  1% BSA for 2 h at 22~  After washing, wells 
were incubated overnight with hyaluronan, chondroitin sulphate, dermatan 
sulphate, or keratan sulphate at several concentrations  ranging from 0-10 
t~g in 100/xl PBS. The wells were washed extensively, incubated with a 
1:1,000 dilution of a rabbit antibovine serum to cd(VI)/c~2(VI) (Kielty et al., 
1991) for 2 h at 22"C, and after a further wash, incubated with a  1:8,000 
dilution of alkaline phosphatase-conjugated  anti-rabbit lgG for 2 h. The 
wells were washed twice in PBS and then twice in alkaline phosphatase 
buffer (100 mM diethanolamine,  pH 9.5, containing  100 mM NaC1 and 5 
mM MgC12), before the addition of 1 mg/ml alkaline phosphatase substrate 
(dNPP). The color intensity was measured at 535 nm after 10 and 30 min. 
In this experiment, the concentration of  bound glycosaminoglycans was also 
determined by direct spectrophotometric  microassay of washed wells after 
incubation with glycosaminoglycans (Farndale et al., 1982). 
In another  approach,  the glycosaminoglycans hyaluronan,  chondroitin 
sulphate, and dermatan sulphate (25/~g/100 fd) were dissolved in PBS and 
bound to wells overnight at 4~  Additional binding sites were blocked with 
1% BSA before overnight incubation with collagen VI (preparation A) (1-10 
/~g//~l), and immunological detection of bound collagen VI was carried out 
as described  above. 
Rotary Shadowing EM 
Control and enzyme-digested aliquots of the excluded material of the salt 
extracts (preparation A)  from 12-h digests were analyzed by rotary shadow- 
ing EM for their content  of intact  high-Mr extracellular  matrix  macro- 
molecules using the mica sandwich technique described  by Mould et al. 
(1985).  In some  experiments,  the high-Mr fraction  from hyaluronidase- 
digested skin (100 #g/ml) was preincubated with hyaluronan (0.1 or I mg/mi 
final concentration) for 30 rain or 4 h at 22"C in column buffer or with the 
purified G1 domain of cartilage pmteoglycan (1 ttg GI/100 ~g collagen VI) 
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rotary shadowing analysis. Fractions were diluted directly into 0.2 M am- 
monium acetate, pH ~0, to a final concentration of ~100 t~g/ml, and 5-~1 
droplets were sandwiched between two sheets of freshly cleaved mica. The 
high-Mr aggregates were allowed to absorb onto the mica surfaces for 5 
min. The mica sandwiches were washed in 0.2 M ammonium acetate and 
then plunged into liquid nitrogen. The sandwiches were split open under 
nitrogen, dried in vacuo, rotary shadowed with platinum wire on a tungsten 
filament at an angle of 4"C,  and then coated with carbon.  The carbon 
replicas were floated offonto distilled water, and picked up on uncoated 200 
mesh copper grids. Specimens  were examined in a JEOL 1200 EX electron 
microscope at 120 kV. Length measurements of the type VI collagen and 
fibrillin aggregates  were carried  out  on  micrographs using  a  modified 
Microsemper software package (Synoptics, Cambridge, UK) on an Olivetti 
M28/Matrox PIPI024  frame store system using a line grating replica of 
2,160 lines/mm. 
Results 
Isolation of  High-M, Aggregates  from Fetal Calf  Skin 
The experiments presented in this paper relate to tissue ob- 
tained from a single bovine fetus from the second trimester 
of gestation (160 d), but identical results were obtained from 
a number of animals of similar ages.  Digestion of fetal skin 
with either bacterial collagenase or hyaluronidase (bovine 
testes) for 18 h resulted in the release of complex mixtures 
of proteins and other components, the majority of which 
were  directly  soluble  in  the  respective  digestion buffers 
(Kielty et al.,  1991b). However, the relative efficiencies of 
the two extraction procedures differed, with '~65%  of the 
original wet weight of the bacterial collagenase-digested tis- 
sue directly soluble in the digestion buffer, compared with 
<40%  for the hyaluronidase digests.  After digestion with 
DNAse I and a centrifugation step, the supernatants contain- 
ing  solubilized molecules  (designated salt extracts)  were 
subjected to gel filtration chromatography on Sepharose CL- 
2B  under  nonreducing,  nondenaturing conditions,  which 
facilitated a  clear  separation of high-Mr  aggregates from 
smaller molecules (Fig. 1 B). Broadly similar profiles were 
obtained by chromatography of  the bacterial collagenase and 
hyaluronidase digests. The excluded peak comprised mole- 
cules with molecular masses in excess of 5  ￿  106. How- 
ever,  while the high-Mr  excluded material from bacterial 
collagenase salt extracts represented ,o15-18 % of the origi- 
nal tissue wet weight, that from hyaluronidase-generated salt 
extracts  represented  a  reduced  proportion  of the  tissue 
(4-7 % wet weight). 
Analysis of  Fractions Containing High-M,  Assemblies 
Electrophoresis. Analysis of both the bacterial collagenase 
and hyaluronidase (bovine testes) salt extracts on 6.5 and 8 % 
SDS-PAGE gels under reducing or nonreducing conditions, 
showed that both extracts contained intact high-Mr compo- 
nents but also a high proportion of smaller molecules with 
molecular masses of <70,000 (including blood proteins and 
digest fragments) (Fig. 1 A). In addition, the hyaluronidase 
digests contained some type I collagen. However, the major 
component of  the excluded fraction of  both extracts migrated 
with an apparent Mr of 140,000 under reducing conditions 
(Fig. 1 C). This component was previously identified as the 
cd(VI)/oe2(VI) component of type VI collagen (Kielty et al., 
1991). Several other high-Mr components were also present 
in these fractions. The type I collagen chains present in the 
original hyaluronidase salt extracts were not detected in the 
Absorbance 
DS  HA  HS CS 
Distance migrated 
Figure 2. Analysis of glycos- 
aminoglyeans  present in a salt 
a  extract  and excluded fraction 
(preparation A) of 18-h bacte- 
rial collagenase-digested  fetal 
bovine skin, by cellulose ace- 
tate  electrophoresis after pa- 
pain digestion and cetyl pyri- 
dinium chloride fractionation. 
Plates were scanned at 632.8 
b  run using a laser densitometer. 
(A) Control, showing  the elec- 
trophoretic positions of der- 
matan  sulphate (DS),  hyal- 
uronan (HA), helauan sulphate 
(HS), and  chondroitin  sul- 
phate (CS). (b) Salt extract, 
containing  hyalurnnan and 
low  levels of dermatan  sui- 
t  phate  and heparan sulphate. 
(C)  Excluded fraction, con- 
taining hyaluronan. 
high-Mr fraction; these were eluted predominantly in the in- 
termediate  column volume.  After further purification of 
collagen VI,  the minor high-Mr  components were largely 
removed. 
Uronic Acid Content. The abundance of uronic acid-con- 
taining molecules varied significantly between the bacterial 
collagenase and hyaluronidase (bovine testes) salt extracts, 
and between the excluded fractions of these digests. This re- 
sult largely reflects the fact that this hyaluronidase digestion 
will have removed hyaluronan as well as chondroitin 4 and 
6 sulphate. The bacterial collagenase salt extracts from 2 g 
skin had a substantial total uronic acid content (15.6 mg), but 
there was a reduced amount in the hyaluronidase salt extracts 
(5.1 mg). Similarly, the total uronic acid content of the col- 
lagenase-digested high-Mr  material was 3.7 mg,  while the 
corresponding fraction from the hyaluronidase digests con- 
tained barely detectable levels. A subsequent analysis of the 
glycosaminoglyeans  content of  the digests and excluded frac- 
tions by cellulose acetate (zip plate) electrophoresis resulted 
in the identification of several glycosaminoglycans. The ma- 
jor component in the collagenase-digested  material was hyal- 
uronan, with low levels of dermatan sulphate and heparan 
sulphate also detected in the original extracts, but not in the 
excluded fraction (Fig. 2). Hyaluronan was not detected in 
the hyaluronidase extracts. 
Rotary Shadowing  EM. The high-M, assemblies isolated 
and partially purified from the colla2enase and hyaluroni- 
dase extracts by gel filtration chromatography (preparation 
A) were visualized by rotary shadowing electron micros- 
copy. By far the major matrix macromolecule isolated from 
both digests was type VI collagen.  There were,  however, 
differences in the sizes of these collagen VI assemblies from 
the two sources. The collagenase-extracted collagen VI ex- 
tracted was identified as very extensive twisting microfibrils, 
in some cases in excess  of 6/zm in length (Kielty et al., 
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after rotary shadowing of  type 
VI collagen isolated from fe- 
tal bovine skin after digestion 
by bacterial coUagenase  or hy- 
aluronidase (bovine testes) in 
the presence of  protease inhib- 
itors,  and fractionated by gel 
filtration on Sepharose CL-2B. 
(,4) Large intact microfibrils of 
collagen VI isolated from 18-h 
bacterial  collagenase-digested 
skin  (preparation A).  (B) 
Large intact  microfibrils  and 
aggregated  microfibrils  of  col- 
lagen VI  isolated  from 4-h 
bacterial collagenase-digested 
skin. (C) Individual tetramers 
and double tetramers of coUa- 
gen VI isolated from 18-h hy- 
aluronidase-digested skin. (D) 
Association of  hyaluronan with 
collagen VI microfibrils  iso- 
lated from 18-h bacterial col- 
lagenase-digested  skin.  The 
hyaluxonan (indicated  by ar- 
rows) has been visualized by 
decoration  with the (}1 frag- 
ment of porcine cartilage pro- 
teoglycan.  (E) A single strand 
of bovine vitreous hyaluronan 
decorated  with  the  G1  frag- 
ment. Bars,  100 rim. 
1991b) (Fig. 3 A). Thin filaments apparently emerged from 
a  high  proportion  of the  beaded  "junction"  domains  and 
microfibril ends. When the tissue digestion by bacterial col- 
lagenase was stopped after only 4 h, the coUagen VI subse- 
quently isolated was present predominantly as enormous lin- 
ear  microfibriUar  aggregates  (Fig.  3  B).  In  contrast,  the 
collagen VI present in the solub'flized high-M~ fraction ob- 
tained by hyaluronidase digestion was predominantly in the 
form of single and double tetramers, and short microtibrillar 
sections  (Fig.  3  C).  In  a  separate  experiment  in  which 
hyaluronan was visualized by decoration with G1 fragment 
of cartilage proteoglycan, we identified a frequent associa- 
tion  of hyaluronan  with  the junctional  domains  and  end 
regions of coUagen VI microfibrils  (Fig.  3, D  and E). 
Digestion of Glycosaminoglycans 
in Collagenase-solubUized High-M~ Fractions 
The effects on the integrity  of the high-Mr collagen VI as- 
semblies (preparations A and 13) of digestion with highly pu- 
rified hy~uronidase (Streptomyces and leech), keratanase, 
and chondroitinase ABC, respectively, were investigated by 
assessing alterations in chromatographic behavior on an ana- 
lytical column of Sepharose 2]3, by comparing  electropho- 
retic  profiles under  reducing  and nonreducing  conditions, 
and by rotary shadowing electron microscopic analysis. 
(,4) The chromatographic profiles of  extracts digested with 
highly purified hyaluronidase showed significant differences 
from that characteristic  of the undigested control (Fig. 4). 
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Figure  4. The effects  of  treatment  with  specific  glycosaminoglycan- 
degrading  enzymes for  3 h at  22~  on  the  chromatographic behav- 
There was both a reduction in the proportion of  material elut- 
ing at the position of Vo relative to the control and concom- 
Rant broadening of this peak, with some material of reduced 
molecular mass now included in the column volume. Diges- 
tion with chondroitinase ABC,  which would degrade any 
dermatan sulphate or residual chondroitin sulphate, had no 
effect on the chromatographic profile of any of the extracts, 
but after keratanase treatment, there was a broadening of  the 
main peal< which had previously eluted exclusively in the 
Vo position. 
(B) The electrophoretic profiles of control and enzyme- 
treated extracts, high-M~ fractions (preparation A) and fur- 
ther purified collagen VI (preparation B) were analyzed on 
6.5, 8, and 2.5 % SDS-PAGE gels. There were no apparent 
differences in the mass of the control and enzyme-treated 
,I(VI/o~2(VI)  component resolved under reducing condi- 
tions on 6.5 or 8% gels and detected by protein staining or 
by Western blotting (Fig. 5, A and B). On 2.5% SDS-PAGE 
gels under nonreducing conditions, the purified collagen VI 
preparation resolved into a diffuse high-Mr component with 
an apparent Mr of 1,000,000 and a second band of apparent 
Mr of 500000  (determined by reference to thyroglobulin) 
together with some material that failed to penetrate the gel 
(Fig.  5  C).  Similar profiles were observed for the kera- 
tanase- and chondroitinase ABC lyase-treated samples, but 
those fractions digested with purified hyaluronidase con- 
tained only the M, 500,000 component. After reduction, all 
protein ran at the dye front. 
(C) Rotary shadowing EM of the hyaluronidase-digested 
samples revealed that the enzyme treatment had a profound 
effect on the morphology of  the collagen VI microfibrils (Fig. 
6).  After 30 min incubation, disruption to microfibril in- 
tegrity was already apparent (Fig. 6, A-C), with dramati- 
cally reduced microfibrillar lengths and single and double 
tetramers appearing after 2 h digestion (Fig. 6, D-F) and 
predominating after overnight digestion (Fig. 6, G-I). There 
was, however, no discernible difference  in the gross morphol- 
ogy of the collagen VI microfibrils of the untreated control, 
the chondroitin ABC lyase-digested, or keratanase-digested 
samples. Neither did the treatment have any disaggregating 
effect on the loose aggregates of adjacent microfihrils ob- 
served predominantly in the 4-h digests (see Fig. 3 B). 
Polymerization of Collagen VI Tetramers 
with Hyaluronan 
An excluded fraction from collagenase-digested skin (prepa- 
ration A) was pretreated with leech hyaluronidase overnight 
at 4~  and then incubated for 30 rain or 4 h at 22~  in the 
presence or absence of added bovine vitreous hyaluronan 
(0.1 mg/ml or 1 mg/ml final concentration) before visualiza- 
ior of the excluded fraction of 18-h bacterial collagenase-digested 
sldn (preparation A). Samples were chromatographed at 22~  on 
an analytical  column of  Sepharose CL-2B under nonreducing, non- 
denaturing  conditions. The column buffer was 0.05 M Tris-HCl, pH 
7.5, containing  0.4 M NaCI. Columns were continuously  monitored 
at OD2so. The positions of the void volume (Vo and total volume 
(It) are indicated. (,4) Untreated control. (B) Streptomyces hyal- 
uronidase. (C)  Leech hyaluronidase. (D)  Chondroitinase ABC 
lyase. (E) Keratanase. 
The Journal of Cell Biology, Volume  118, 1992  984 Figure  5. Electrophoretic analysis of  type VI collagen  before and after treatment with specific  glycosaminoglycan-degrading  enzymes. There 
was no degradation of the individual chains of collagen VI (indicated by/arge arrowheads)  under any of these conditions (A and B). How- 
ever, digestion with Streptomyces hyaluronidase  or leech hyaluronidase  did effect a reduction in the macromolecular mass of collagen VI 
from high-Mr aggregates (C). Resolved proteins were detected by staining with Coomassie brilliant blue (tracks 1-3 and 7-16) and the 
cd(VI)/c~2(VI) component was identified by Western blotting using specific polyclonal antiserum (Kielty et al., 1991b) (tracks 4-6). (A) 
Salt extracts from 18-h bacterial coUagenase-digested  skin analyzed on 6.5% SDS-PAGE gels under reducing conditions. (Tracks I and 
4) Untreated controls; (tracks 2 and 5) samples treated with leech hyahronidase; (tracks 3 and 6) samples treated with keratanase. (B) 
Purified collagen VI (preparation B) analyzed on 8% SDS-PAGE gels under reducing conditions. (Track 7) Untreated control; (tracks 
8-11) samples treated with Streptomyces  hyaluronidase,  leech hyaluronidase,  chondroitinase  ABC lyase, and keratanase, respectively.  Note: 
the chondroitinase ABC lyase enzyme preparation contains carrier protein. (C) Purified collagen VI (preparation B) analyzed on 2.5% 
SDS-PAGE gels under nonreducing conditions. (Track 12) Untreated control; (tracks 13-16) samples treated with keratanase, chon- 
droitinase ABC lyasc, Streptomyces hyaluronidase, and leech hyaluronidase, respectively. 
tion  by  rotary  shadowing  electron  microscopy  (Fig.  7). 
While the control (zero time) samples contained mostly sin- 
gle tetramers (Fig. 7 E), those incubated for 30 min in the 
presence of hyaluronan contained both tetramers and short 
microfibrillar sections (Fig. 7, B and F), and the 4-h samples 
contained substantially longer collagen VI microfibrils of  up 
to 15 tetramer units in length (Fig. 7, C, G, H). This experi- 
ment  therefore  provided  clear  evidence  that  the  added 
hyaluronan had facilitated an in vitro polymerization of col- 
lagen VI tetramers. 
Binding of  Intact l~pe VI Collagen to Hyaluronan 
The binding of hyaluronan, keratan sulphate,  chondroitin 
sulphate, and dermatan sulphate to intact type VI collagen 
was investigated in ELISA-type binding studies in one of  two 
ways,  Soluble intact collagen VI  (preparation A)  was im- 
mobilized in microtitre wells and incubated with different 
concentrations of glycosaminoglycans, or glycoaminogly- 
cans were adsorbed onto the wells and incubated with colla- 
gen VI. In the first case, the binding of  different  glycosamino- 
glycans to  immobilized collagen VI  clearly  showed that 
incubation with hyaluronan was most effective in blocking 
the interaction of collagen VI with antibody (Fig. 8 A). Of 
the other glycosaminoglycans tested, only keratan sulphate 
showed any inhibition, and this was at a much higher concen- 
tration. When glycosaminoglycans were bound to the wells 
and subsequently reacted with collagen type VI, the presence 
of hyaluronan led to the retention and detection of most col- 
lagen VI,  with keratan  sulphate also  apparently binding 
weakly to collagen VI (Fig. 8 B). Despite the poor attach- 
ment of  glycosaminoglycans  to the wells, the similar findings 
between the two approaches indicate a specific interaction 
between collagen VI and hyaluronan. 
Discussion 
We have presented biochemical, immunochemical, and ul- 
trastructural  evidence for an interaction between type VI 
collagen and the long, unbranched polysaccharide, hyaluro- 
nan. This analysis was facilitated by our recent development 
of an efficient method for extracting intact type VI collagen 
microfibrils from fetal tissues after removal of the fibrillar 
collagen framework (Kielty et al., 1991b). This protocol re- 
leases abundant and extensive collagen VI microfibrillar ar- 
rays, which confirm the primary location of this collagen 
in vivo among the interstitial collagen fibrils. In .the pres- 
ent work,  we have demonstrated that the collagen VI ex- 
tracted after hyaluronidase-induced  tissue disruption differed 
in several important respects from the bacterial coUagenase- 
released material. The yield of hyaluronidase-extracted col- 
lagen VI was not only markedly lower than that released by 
bacterial collagenase  digestion, but it was also predominantly 
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graphs after rotary shadowing 
of  collagen VI (preparation A) 
after treatment with leech hy- 
aluronidase at 22~  for 30 rain 
(A-C), 2 h (D-F) and over- 
night  (G--l).  A  progressive 
depolymerization  of collagen 
VI  microfibrils  is  apparent 
under these conditions. 
in the form of single and double tetramers and short micro- 
fibrillar  sections.  Another  notable difference between the 
collagen VI extracted by the two enzyme treatments was the 
lack of ultrastrucmral evidence for any association with thin 
filamentous strands at tetrameric  junctions or extruding from 
microfibrillar ends such as are frequently observed in the 
bacterial collagenase-released collagen VI. These initial ob- 
servations prompted us to investigate further the molecular 
basis of these gross structural differences, and the possibility 
of  a  physiological  relationship  between collagen  Vl  and  hyal- 
uronan. 
We have demonstrated the  presence of  abundant hyaluro- 
nan in  the fetal  skin  extracts  and in  the  high-Mr aggregates 
isolated  by gel filtration  chromatography.  Indeed, hy~uro- 
nan makes the  principle  contribution  to  the  uronic acid  con- 
tent  of  this  tissue,  although low levels  of  dermatan sulphate 
and heparan sulphate  were also  detected  in  this  tissue.  The 
effects  on the intact  coUagcnase-released type VI collagen 
The Journal of Cell Biology, Volume 118, 1992  986 Figure  7.  Electron  micro- 
graphs after rotary shadowing 
of  collagen VI (preparation A) 
after treatment with leech hy- 
aluronidase  and  subsequent 
incubation for 30 min or 4 h 
at  22~  in  the  presence  of 
0A mg/ml (A-C) or 1 mg/ml 
bovine  vitreous  hyaluronan  (D- 
H). The association of hyal- 
uronan with the globular junc- 
tional  and  end  domains  of 
collagen VI tetramers and mi- 
crofibrillar  sections  can  be 
clearly seen. A and D contain 
hyalumnan only. Control sam- 
ples  (zero  incubation  time) 
contained mostly collagen VI 
tetrarners  and  double  tetra- 
mers (E). After 30 min of in- 
cubation,  short  collagen  VI 
mierofibrillar arrays could be 
detected (B and F). After 4 h 
of incubation,  longer micro- 
fibrils of up to  15  tetramer 
units were frequently observed 
(C, G, H). Bars,  100 ran. 
microfibrils of treatment (in the presence of protease inhib- 
itors)  with  highly  purified  hyaluronidase,  chondroitinase 
ABC, or keratanase, were investigated using a combination 
of gel filtration chromatography, electrophoresis, and rotary 
shadowing EM. This approach demonstrated that while the 
individual  chains,  triple-helical  monomers,  dimers,  and 
tetramers were undegraded by any of these treatments, there 
was a shift in the size distribution of the collagen VI micro- 
fibrils after hyaluronidase digestion, with short microfibril- 
lar sections, tetramers, dimers, and also individual chains 
generated by this treatment. A small amount of collagen VI 
depolymerization was also observed on treatment with kera- 
tanase, although the physiological significance of this obser- 
vation is unclear. The chondroitinase ABC lyase treatment 
failed to influence the size distribution or morphology of the 
collagen VI microfibrils. We have also been able to demon- 
strate in a converse approach, that incubation of hyaluron- 
idase-digested collagen VI with an excess of purified high- 
Mr hyaluronan facilitates a  partial repolymerization of the 
micmfibrils.  A  separate  ultrastructural  investigation  of a 
high-M, excluded fraction revealed that hyaluronan, clearly 
visualized by decoration with the G1  fragment of cartilage 
proteoglycan, was frequently associated with the globular 
junctional and end domains of  intact collagen VI micmfibrils. 
Finally, we have shown in an in vitro assay that collagen VI 
is indeed able to bind strongly to hyaluronan. It also appears 
to interact with keratan sulphate, but with a much lower af- 
finity.  Taken together, these data provide compelling evi- 
dence for a physiological association between collagen VI 
and hyaluronan which has important implications for their 
biological roles and mechanisms of  action in tissue organiza- 
tion and remodeling. 
The chemical nature of the association between collagen 
VI and hyaluronan is not clear from the present work. How- 
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Figure & Binding of glycosaminoglycans to collagen VI. The binding of different glycosaminoglycans to collagen VI was determined by 
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glycan was determined by ELISA. 
ever, the available ultrastructural  information points to the 
primary  involvement of the  (largely  nonhelical)  terminal 
regions of collagen VI, and not the central red-like helical 
domain, in this interaction. Possibilities include a relatively 
nonspeeific  hydrophobic  association  between  hyaluronan 
and the globular domains  of collagen VI such as that en- 
visaged as a basis of potential hyaluronan interactions with 
proteins and lipid membranes by Scott (1989), or possibly 
a highly specific (hydrophobic) interaction between hyaluro- 
nan and a hyaluronan-binding  site. One family of proteins 
with a hyaluronan-binding motif has been identified and this 
includes cartilage  proteoglycan,  link protein,  and the cell 
surface hyaluronan  receptor,  CD-44  (Aruffo et al.,  1990; 
Culty et al., 1990). We have been unable to identify any such 
obvious motif in the chains of collagen VI; however, they 
may combine to form a  new class of hyMuronan-binding 
domain. 
The hyaluronan network is an integral structure, which ap- 
pears not to require other components to hold it together 
(Scott et al.,  1991).  Indeed, the formation of extensive and 
continuous secondary and tertiary structures appear to be 
driven by interactions between the large repeating hydropho- 
bic patches on alternate sides of this molecule. Furthermore, 
the overall strength of the meshwork is likely to be dependent 
on the size of the component hyaluronan  molecules,  with 
shorter molecules with fewer potential cross-links generat- 
ing weaker meshworks, for example, in rheumatoid arthritis 
where a pathological decrease in the size of byaluronan mol- 
ecules apparently affects the lubricating qualities of synovial 
fluid.  Hyaluronan  also  interacts  with  proteoglycans,  cell 
membranes  and receptors  such as CD-44  with very high 
specificity  (Evered  and  Whelan,  1988;  Gallagher,  1989; 
Aruflb et al., 1990; Culty et al., 1990). Thus, this relatively 
simple long tmbranehed polysaccharide is capable of enor- 
mous specificity  and  versatility.  Type  VI  collagen  is,  in  con- 
trast,  a highly  complex macromolecule. The extent  of its 
complexity  has recently  become apparent  with  the  elucida- 
tion of the complete cDNA sequence (Bonaldo et al.,  1989; 
Bonaldo  and  Colombatti,  1990;  Chu  et al.,  1988,  1989, 
1990; Trueb et al.,  1989) with evidence for discrete (poten- 
flatly functional)  sequence motifs in  all three chains  and 
tissue-specific alternative splicing of the ct2(VI) and ot3(VI) 
chains.  Furthermore,  although the sequence of intracellular 
events leading to the formation of monomers,  dimers,  and 
tetrarners has been well established in biosynthetic studies 
(Engvall et al.,  1986; Colombatti and Bonaldo,  1987), the 
chemical  basis of the polymerization  of type VI collagen 
tetramers into microfibrils in the extracellular space is not 
well  established.  The  involvement  of  aldehyde-derived 
cross-links  has  been  virtually  excluded,  and  disulphide 
bonds also appear not to play a primary role in this interac- 
tion (Wu et al.,  1987; Kielty et al.,  1991b), which might be 
hydrophobic or ionic in nature.  It is therefore particularly 
tempting to speculate on a possible role for hyaluronan in 
directing the polymerization of collagen VI microfibrils in 
the  extracellular  space proximal  to the  cellular  basement 
membrane from which it is extruded. However, it is far from 
clear whether the association of hyaluronan with collagen VI 
is  of such fundamental  structural  importance,  whether  it 
may  play  a  role  in  lateral  aggregation  of  collagen  VI 
microfibrils, or whether it simply acts as a primary stabiliz- 
ing  influence  on  the  collagen  VI  microfibrillar  network. 
What is clear is that removal of hyaluronan  renders  these 
microfibrillar  structures  far  less  stable  entities  with  in- 
creased susceptibility to depolymerization.  At a functional 
level, hyaluronan might act to modulate collagen VI-matrix 
or  -cell  interactions,  for  example,  by  masking  cell-  or 
collagen-binding  sequences,  or by acting  in  a  synergistic 
manner with collagen VI to strengthen specific interactions. 
Some clues as to which, if any, of these options may apply 
could  come  from  analysis  of certain  disease  conditions 
where perturbations in the structure and abundance of both 
hyaluronan and type VI collagen have been recorded.  Fur- 
ther work is currently in progress to elucidate not only the 
The  Journal  of Cell  Biology,  Volume  118,  1992  988 molecular basis of the specific collagen VI-hyaluronan inter- 
action, but also the physiological significance of the collagen 
VI interactions in vivo with hyaluronan, and possibly  other 
glycosaminoglycans  or proteoglycans. 
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